FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Copaxone Recall

Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged…

Teva Pharmaceuticals USA · Horsham, PA

Risk level
Class II
Reported by FDA
Nov 27, 2013
Recall ID
D-001-2014
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Copaxone starting Oct 24, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-001-2014 on Nov 27, 2013. Reason: Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.

Product description

Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-use PRE-FILLED Syringes and 33 Alcohol Preps (Swabs) per carton, Rx only, Marketed by: Teva Neuroscience, Inc., Kansas City, MO 64131; Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 68546-317-30, UPC 3 68546 31730 4.

Lot numbers, UPCs & expiration codes

Lot X06381, Exp 10/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-001-2014
Classification
Class II
Status
Terminated
Recall initiated
Oct 24, 2013
FDA report date
Nov 27, 2013
Quantity
6,803 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-001-2014, exactly as published.

Show all FDA fields
City
Horsham
State
PA
Status
Terminated
Country
United States
Event ID
66672
Address
425 Privet Rd
Code information
Lot X06381, Exp 10/14
Postal code
19044-1220
Report date
Nov 27, 2013
Product type
Drugs
Recall number
D-001-2014
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
6,803 cartons
Termination date
Aug 27, 2014
Reason for recall
Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-use PRE-FILLED Syringes and 33 Alcohol Preps (Swabs) per carton, Rx only, Marketed by: Teva Neuroscience, Inc., Kansas City, MO 64131; Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 68546-317-30, UPC 3 68546 31730 4.
Distribution pattern
Nationwide
Recall initiation date
Oct 24, 2013
Initial firm notification
Letter
Center classification date
Nov 20, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-001-2014, published Nov 27, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls